Cabenuva is a combination prescription drug approved by the U.S. Food and Drug Administration (FDA) to treat adults with HIV-1 infection. It is a complete treatment regimen that includes cabotegravir and rilpivirine, which work together to prevent the HIV-1 virus from replicating inside body cells.

Common side effects read more

Cabenuva is a combination prescription drug approved by the U.S. Food and Drug Administration (FDA) to treat adults with HIV-1 infection. It is a complete treatment regimen that includes cabotegravir and rilpivirine, which work together to prevent the HIV-1 virus from replicating inside body cells.

Common side effects include:
- Injection site reactions
- Fever
- Fatigue
- Headache
- Muscle pain
- Nausea
- Sleep disorders
- Dizziness
- Rash

Serious side effects include:
- Hypersensitivity reactions
- Serious post-injection reactions
- Liver damage
- Symptoms of depression

For more details, you can visit the official Cabenuva website or the FDA announcement.

 This AI-generated response comes from myHIVteam and other selected sources. It is not a substitute for medical advice. Always ask your doctor about specific health concerns.

Cabenuva (Cabotegravir/Rilpivirine) for HIV | myHIVteam

Injectables for HIV Treatment and Prevention: How They Work | myHIVteam